Evaluation of anti-SARS-CoV-2 antibody testing in asymptomatic or mild COVID-19 patients in outbreak on a cruise ship

Norihito Kaku, Fumitaka Nishimura, Yui Shigeishi, Rina Tachiki, Hironori Sakai, Daisuke Sasaki, Kenji Ota, Kei Sakamoto, Kosuke Kosai, Hiroo Hasegawa, Koichi Izumikawa, Koya Ariyoshi, Hiroshi Mukae, Jiro Yasuda, Kouichi Morita, Shigeru Kohno, Katsunori Yanagihara
doi: https://doi.org/10.1101/2021.03.10.21253064

Data Availability

Raw data were generated at Nagasaki University Hospital. Derived data supporting the findings of this study are available from the corresponding author upon request.

Back to top
Posted March 16, 2021.
Download PDF
Data/Code
Email
Evaluation of anti-SARS-CoV-2 antibody testing in asymptomatic or mild COVID-19 patients in outbreak on a cruise ship
Norihito Kaku, Fumitaka Nishimura, Yui Shigeishi, Rina Tachiki, Hironori Sakai, Daisuke Sasaki, Kenji Ota, Kei Sakamoto, Kosuke Kosai, Hiroo Hasegawa, Koichi Izumikawa, Koya Ariyoshi, Hiroshi Mukae, Jiro Yasuda, Kouichi Morita, Shigeru Kohno, Katsunori Yanagihara
medRxiv 2021.03.10.21253064; doi: https://doi.org/10.1101/2021.03.10.21253064
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area